Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.

Jung M, Ellinger J, Gevensleben H, Syring I, Lüders C, de Vos L, Pützer S, Bootz F, Landsberg J, Kristiansen G, Dietrich D.

Clin Chem. 2019 Jan 9. pii: clinchem.2018.297549. doi: 10.1373/clinchem.2018.297549. [Epub ahead of print]

PMID:
30626634
2.

Etiology, Management, and Outcome of Pediatric Epistaxis.

Send T, Bertlich M, Eichhorn KW, Ganschow R, Schafigh D, Horlbeck F, Bootz F, Jakob M.

Pediatr Emerg Care. 2019 Jan 7. doi: 10.1097/PEC.0000000000001698. [Epub ahead of print]

PMID:
30624421
3.

Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature.

Send T, Spiegel JL, Schade G, Pantelis A, Olthoff A, Bootz F, Canis M, Jakob M.

Dysphagia. 2018 Oct 31. doi: 10.1007/s00455-018-9956-x. [Epub ahead of print]

PMID:
30382384
4.

Management and outcome of epistaxis under direct oral anticoagulants: a comparison with warfarin.

Send T, Bertlich M, Horlbeck F, Schafigh D, Freytag S, Eichhorn KW, Gräff I, Bootz F, Jakob M.

Int Forum Allergy Rhinol. 2019 Jan;9(1):120-124. doi: 10.1002/alr.22210. Epub 2018 Oct 3.

PMID:
30281938
5.

Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.

Vogt TJ, Gevensleben H, Dietrich J, Kristiansen G, Bootz F, Landsberg J, Goltz D, Dietrich D.

Oncoimmunology. 2018 Apr 18;7(8):e1452579. doi: 10.1080/2162402X.2018.1452579. eCollection 2018.

PMID:
30221045
6.

Management and Follow-up Results of Salivary Fistulas Treated With Botulinum Toxin.

Send T, Bertlich M, Eichhorn KW, Bootz F, Jakob M.

Laryngoscope. 2018 Aug 27. doi: 10.1002/lary.27416. [Epub ahead of print]

PMID:
30151958
7.

CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.

Goltz D, Gevensleben H, Vogt TJ, Dietrich J, Golletz C, Bootz F, Kristiansen G, Landsberg J, Dietrich D.

JCI Insight. 2018 Jul 12;3(13). pii: 96793. doi: 10.1172/jci.insight.96793. [Epub ahead of print]

8.

Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.

Bergheim J, Semaan A, Gevensleben H, Groening S, Knoblich A, Dietrich J, Weber J, Kalff JC, Bootz F, Kristiansen G, Dietrich D.

Br J Cancer. 2018 May;118(9):1217-1228. doi: 10.1038/s41416-018-0035-8. Epub 2018 Apr 3.

PMID:
29610456
9.

Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.

Semaan A, Uhl B, Branchi V, Lingohr P, Bootz F, Kristiansen G, Kalff JC, Matthaei H, Pantelis D, Dietrich D.

Clin Colorectal Cancer. 2018 Jun;17(2):e385-e393. doi: 10.1016/j.clcc.2018.02.008. Epub 2018 Feb 23.

PMID:
29580650
10.

Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.

Sailer V, Charpentier A, Dietrich J, Vogt TJ, Franzen A, Bootz F, Dietrich D, Schroeck A.

PLoS One. 2018 Feb 9;13(2):e0192742. doi: 10.1371/journal.pone.0192742. eCollection 2018.

11.

PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.

Franzen A, Vogt TJ, Müller T, Dietrich J, Schröck A, Golletz C, Brossart P, Bootz F, Landsberg J, Kristiansen G, Dietrich D.

Oncotarget. 2017 Dec 7;9(1):641-650. doi: 10.18632/oncotarget.23080. eCollection 2018 Jan 2.

12.

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.

Röver LK, Gevensleben H, Dietrich J, Bootz F, Landsberg J, Goltz D, Dietrich D.

EBioMedicine. 2018 Feb;28:97-104. doi: 10.1016/j.ebiom.2018.01.016. Epub 2018 Jan 31.

13.

[Rare cause of a supraclavicular swelling].

Bartmann D, Koppen T, Pieper CC, Bootz F, Send T.

HNO. 2018 Jun;66(6):485-488. doi: 10.1007/s00106-018-0472-y. German. No abstract available.

PMID:
29356858
14.

Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.

de Vos L, Gevensleben H, Schröck A, Franzen A, Kristiansen G, Bootz F, Dietrich D.

Clin Epigenetics. 2017 Dec 1;9:125. doi: 10.1186/s13148-017-0425-4. eCollection 2017.

15.

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma.

Müller T, Braun M, Dietrich D, Aktekin S, Höft S, Kristiansen G, Göke F, Schröck A, Brägelmann J, Held SAE, Bootz F, Brossart P.

Oncotarget. 2017 May 2;8(32):52889-52900. doi: 10.18632/oncotarget.17547. eCollection 2017 Aug 8.

16.

RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.

Coch C, Stümpel JP, Lilien-Waldau V, Wohlleber D, Kümmerer BM, Bekeredjian-Ding I, Kochs G, Garbi N, Herberhold S, Schuberth-Wagner C, Ludwig J, Barchet W, Schlee M, Hoerauf A, Bootz F, Staeheli P, Hartmann G, Hartmann E.

Mol Ther. 2017 Sep 6;25(9):2093-2103. doi: 10.1016/j.ymthe.2017.07.003. Epub 2017 Jul 8.

17.

[Rare cervical soft tissue tumor].

Send T, Isselstein LJ, Eichhorn KW, Greschus S, Bootz F, van Bremen T.

HNO. 2017 Dec;65(12):1018-1022. doi: 10.1007/s00106-017-0374-4. German. No abstract available.

PMID:
28667387
18.

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.

Sailer V, Gevensleben H, Dietrich J, Goltz D, Kristiansen G, Bootz F, Dietrich D.

PLoS One. 2017 Jun 15;12(6):e0179412. doi: 10.1371/journal.pone.0179412. eCollection 2017.

19.

Robot-assisted endoscope guidance versus manual endoscope guidance in functional endonasal sinus surgery (FESS).

Eichhorn KW, Westphal R, Rilk M, Last C, Bootz F, Wahl F, Jakob M, Send T.

Acta Otolaryngol. 2017 Oct;137(10):1090-1095. doi: 10.1080/00016489.2017.1336284. Epub 2017 Jun 9.

PMID:
28598713
20.

Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.

Schröck A, Leisse A, de Vos L, Gevensleben H, Dröge F, Franzen A, Wachendörfer M, Schröck F, Ellinger J, Teschke M, Wilhelm-Buchstab T, Landsberg J, Holdenrieder S, Hartmann G, Field JK, Bootz F, Kristiansen G, Dietrich D.

Clin Chem. 2017 Jul;63(7):1288-1296. doi: 10.1373/clinchem.2016.270207. Epub 2017 May 17.

21.

PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.

Goltz D, Gevensleben H, Dietrich J, Schroeck F, de Vos L, Droege F, Kristiansen G, Schroeck A, Landsberg J, Bootz F, Dietrich D.

Oncotarget. 2017 Jun 20;8(25):41011-41020. doi: 10.18632/oncotarget.17354.

22.

[PET-CT in head and neck cancer].

Send T, Kreppel B, Gaertner FC, Bundschuh RA, Strunk H, Bootz F, Essler M.

HNO. 2017 Jun;65(6):504-513. doi: 10.1007/s00106-017-0355-7. Review. German.

PMID:
28451717
23.

[Interventional radiology in the head and neck region].

Mayer C, Hattingen E, Schild H, Bootz F, Schröck A.

HNO. 2017 Jun;65(6):482-489. doi: 10.1007/s00106-017-0354-8. Review. German.

PMID:
28451716
24.

[Imaging in otorhinolaryngology].

Bootz F.

HNO. 2017 Jun;65(6):460-461. doi: 10.1007/s00106-017-0356-6. German. No abstract available.

PMID:
28451715
25.

[Imaging for surgical planning : Tumor surgery including reconstructive procedures].

Bootz F, Greschus S.

HNO. 2017 Jun;65(6):472-481. doi: 10.1007/s00106-017-0343-y. Review. German.

PMID:
28353078
26.

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.

Sailer V, Holmes EE, Gevensleben H, Goltz D, Dröge F, Franzen A, Dietrich J, Kristiansen G, Bootz F, Schröck A, Dietrich D.

Clin Epigenetics. 2017 Feb 2;9:12. doi: 10.1186/s13148-017-0317-7. eCollection 2017.

27.

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.

Laban S, Giebel G, Klümper N, Schröck A, Doescher J, Spagnoli G, Thierauf J, Theodoraki MN, Remark R, Gnjatic S, Krupar R, Sikora AG, Litjens G, Grabe N, Kristiansen G, Bootz F, Schuler PJ, Brunner C, Brägelmann J, Hoffmann TK, Perner S.

Oncotarget. 2017 Feb 28;8(9):14719-14735. doi: 10.18632/oncotarget.14830.

28.

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.

von Mässenhausen A, Brägelmann J, Billig H, Thewes B, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Brossart P, Kirfel J, Perner S.

Int J Mol Sci. 2016 Dec 22;18(1). pii: E7. doi: 10.3390/ijms18010007.

29.

The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Fugmann T, Sofron A, Ritz D, Bootz F, Neri D.

J Immunol. 2017 Feb 1;198(3):1357-1364. doi: 10.4049/jimmunol.1601157. Epub 2016 Dec 23.

30.

Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients.

Meller S, VAN Ellen A, Gevensleben H, Bicker A, Hankeln T, Gorr TA, Sailer V, Dröge F, Schröck F, Bootz F, Schröck A, Perner S, Dietrich D, Kristiansen G.

Anticancer Res. 2016 Dec;36(12):6235-6241.

PMID:
27919941
31.

[Diagnosis and treatment of parapharyngeal space tumors].

Bootz F, Greschus S, van Bremen T.

HNO. 2016 Nov;64(11):815-821. Review. German.

PMID:
27757479
32.

[Dysphonia and Dysphagia Caused by a Pedunculated Polyp of the Hypopharynx].

Schwarte B, Bootz F, Zhou H, Schade G.

Laryngorhinootologie. 2016 Oct;95(10):702-703. doi: 10.1055/s-0042-109614. Epub 2016 Jul 14. German. No abstract available.

PMID:
27414484
33.

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.

Sailer V, Holmes EE, Gevensleben H, Goltz D, Dröge F, de Vos L, Franzen A, Schröck F, Bootz F, Kristiansen G, Schröck A, Dietrich D.

Oncotarget. 2016 Nov 15;7(46):75827-75838. doi: 10.18632/oncotarget.12417.

34.

Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.

Bootz F, Venetz D, Ziffels B, Neri D.

Protein Eng Des Sel. 2016 Oct;29(10):445-455. doi: 10.1093/protein/gzw038. Epub 2016 Aug 11.

35.

Antibody-Based Targeted Delivery of Interleukin-22 Promotes Rapid Clinical Recovery in Mice With DSS-Induced Colitis.

Bootz F, Ziffels B, Neri D.

Inflamm Bowel Dis. 2016 Sep;22(9):2098-105. doi: 10.1097/MIB.0000000000000851.

PMID:
27482975
36.

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

von Mässenhausen A, Sanders C, Brägelmann J, Konantz M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Lengerke C, Perner S.

Int J Cancer. 2016 Nov 15;139(10):2359-69. doi: 10.1002/ijc.30279. Epub 2016 Jul 30.

37.

Interdisziplinäre Versorgung von Kindern nach Fremdkörper aspiration und Fremdkörperingestion.

Eich C, Nicolai T, Hammer J, Deitmer T, Schmittenbecher P, Schubert KP, Laschat M, Sittel C, Claßen M, Becke K, Bootz F, Höhne C, Jungehülsing M, Windfuhr J.

Laryngorhinootologie. 2016 May;95(5):321-31. doi: 10.1055/s-0042-102614. Epub 2016 May 2. Review. German. No abstract available.

PMID:
27135426
38.

MERTK as a novel therapeutic target in head and neck cancer.

von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S.

Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724.

39.

Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.

von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S.

Target Oncol. 2016 Oct;11(5):631-642.

PMID:
27053219
40.

Kombiniertes Silent-Sinus-Syndrom der Kiefer- und Stirnhöhle.

Goldstein J, Hadizadeh DR, Bootz F.

Rofo. 2016 Jun;188(6):583-4. doi: 10.1055/s-0042-101252. Epub 2016 Mar 16. German. No abstract available.

PMID:
26981916
41.

[Early recognition of cancerous lesions in the mouth and oropharynx: Automated evaluation of hyperspectral image stacks].

Laffers W, Westermann S, Regeling B, Martin R, Thies B, Gerstner AO, Bootz F, Müller NA.

HNO. 2016 Jan;64(1):27-33. doi: 10.1007/s00106-015-0109-3. German.

PMID:
26676521
42.

[Evaluation and Optimization of Microvascular Arterial Anastomoses by Transit Time Flow Measurement].

Herberhold S, Röttker J, Bartmann D, Solbach A, Keiner S, Welz A, Bootz F, Laffers W.

Laryngorhinootologie. 2016 Mar;95(3):178-81. doi: 10.1055/s-0035-1564186. Epub 2015 Dec 15. German.

PMID:
26669581
43.

Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.

Bootz F, Neri D.

Drug Discov Today. 2016 Jan;21(1):180-189. doi: 10.1016/j.drudis.2015.10.012. Epub 2015 Oct 23. Review.

44.

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.

Göke F, Franzen A, Hinz TK, Marek LA, Yoon P, Sharma R, Bode M, von Maessenhausen A, Lankat-Buttgereit B, Göke A, Golletz C, Kirsten R, Boehm D, Vogel W, Kleczko EK, Eagles JR, Hirsch FR, Van Bremen T, Bootz F, Schroeck A, Kim J, Tan AC, Jimeno A, Heasley LE, Perner S.

Clin Cancer Res. 2015 Oct 1;21(19):4356-64. doi: 10.1158/1078-0432.CCR-14-3357. Epub 2015 May 26.

45.

Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.

Bootz F, Schmid AS, Neri D.

Inflamm Bowel Dis. 2015 Aug;21(8):1908-17. doi: 10.1097/MIB.0000000000000440.

PMID:
25993691
46.

Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.

Shaikhibrahim Z, Offermann A, Halbach R, Vogel W, Braun M, Kristiansen G, Bootz F, Wenzel J, Mikut R, Lengerke C, Reischl M, Schröck A, Perner S.

Am J Pathol. 2015 Apr;185(4):1114-22. doi: 10.1016/j.ajpath.2014.12.010. Epub 2015 Mar 16.

PMID:
25791637
47.

[Change of Taste during and after IM- /IG-Radiotherapy for Head and Neck Cancer Patients].

Leitzen C, Herberhold S, Wilhelm-Buchstab T, Garbe S, Müdder T, Schoroth F, Schild HH, Bootz F, Schüller H.

Laryngorhinootologie. 2015 Jun;94(6):383-7. doi: 10.1055/s-0034-1390430. Epub 2014 Dec 1. German.

PMID:
25437837
48.

Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes.

Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, Mauel K, Jäger M, Flohé SB, Lang S.

PLoS One. 2014 Sep 19;9(9):e106903. doi: 10.1371/journal.pone.0106903. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e114201.

49.

Diagnostic imaging modalities in head and neck disease.

Dammann F, Bootz F, Cohnen M, Hassfeld S, Tatagiba M, Kösling S.

Dtsch Arztebl Int. 2014 Jun 9;111(23-24):417-23. doi: 10.3238/arztebl.2014.0417. Review.

50.

Workspace and pivot point for robot-assisted endoscope guidance in functional endonasal sinus surgery (FESS).

Eichhorn KW, Westphal R, Last C, Rilk M, Bootz F, Wahl FM, Jakob M.

Int J Med Robot. 2015 Mar;11(1):30-7. doi: 10.1002/rcs.1599. Epub 2014 Jun 18.

PMID:
24941911

Supplemental Content

Support Center